The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Jørgensen has agreed to stay on while the search for a successor is carried out, and the chair of the Novo Nordisk Foundation ...

Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.

People on GLP-1 medication seem to be adding more protein to their diets, further increasing demand for chicken and beef at a ...

The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company's board of directors, citing ...